Cryopreservation equipment market to hit $22.53B by 2030

The cryopreservation equipment market is projected to grow from $11.01 billion in 2025 to $22.53 billion by 2030 as demand rises for biobanking, regenerative medicine and long-term biological sample storage. North America leads now, while Asia-Pacific is expected to grow fastest.

Why it matters: - Cryopreservation equipment is becoming essential to biotechnology, regenerative medicine and biobanking. - The market’s projected rise to $22.53 billion by 2030 signals sustained demand for ultra-low temperature storage and automated sample-handling systems. - Growth in stem cell banking, embryo and oocyte preservation, and clinical research is expanding the real-world use of these systems.

What happened: - The cryopreservation equipment market was valued at $11.01 billion in 2025. - The market is projected to reach $12.74 billion in 2026. - The market is forecast to hit $22.53 billion by 2030. - The forecast implies a 15.7% CAGR from 2025 to 2026 and a 15.3% CAGR through 2030. - The Business Research Company published the market research covering size, drivers, regional trends and outlook. - The report offers a free sample and the full market report.

The details: - Cryopreservation equipment includes ultra-low temperature freezers, cryogenic storage tanks and accessories. - These systems preserve cells, tissues and organs at temperatures often below minus 150 degrees Celsius. - Liquid nitrogen and mechanical refrigeration are used to suspend biological activity. - The equipment supports regenerative medicine, biobanking and scientific research. - Drivers behind the market include limited availability of ultra-low temperature freezers in the past, manual sample handling, growing stem cell banking and broader adoption of cryogenic safety protocols. - Automated freezing and thawing systems are expected to speed up preservation workflows. - Investments in biobanking and stem cell research are adding to demand for long-term storage capacity. - Demand for embryo and oocyte preservation is also supporting market expansion. - Smart monitoring systems and IoT-enabled cryogenic devices are changing how samples are tracked and secured. - Regulatory compliance and quality certifications are helping reinforce product safety and efficacy. - In 2025, North America held the largest market share. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The regional scope also includes South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market outlook is being shaped by a shift from manual preservation processes to more automated and connected systems. - Regenerative medicine is creating a larger installed base of biological materials that must be stored reliably for longer periods. - Clinical trial activity suggests the pipeline for cell and gene therapies is broadening, which can support future cryopreservation demand. - Data from The Catapult showed that gene therapy, cell therapy and tissue-engineered product trials made up 9.5% of global trials in 2024 and nearly half of European trials.

What's next: - Market growth is likely to track further investments in regenerative medicine, biobanking and advanced storage infrastructure. - Adoption of automated and IoT-linked cryogenic systems should continue as labs seek tighter control and traceability. - Asia-Pacific could narrow the gap with mature markets as healthcare access and research spending increase. - The Business Research Company says its 2026 reports add market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards and updated graphics and tables.

The bottom line: - Cryopreservation equipment is moving from a niche storage category to a core enabling technology for modern biomedical research and therapy development.